Diabetes And Fentanyl
This is a study to compare the effects of fentanyl buccal to immediate release oxycodone in alleviating breakthrough pain in opioid-tolerant patients with chronic pain. This national study is currently recruiting adults who suffer from chronic pain due to such conditions as diabetic peripheral neuropathy, postherpetic neuralgia, traumatic injury, complex regional pain syndrome, back pain, neck pain, fibromyalgia, chronic pancreatitis, osteoarthritis, rheumatoid arthritis, or cancer.
Read moreMore information on "Diabetes And Fentanyl"
From Our Experts
Keeping Duragesic (Fentanyl) Patches On
While fentanyl patches can be very effective for relieving chronic pain, sometimes keeping them from falling off presents quite a... Read more »
FDA Approves REMS for Transmucosal Immediate-Release Fentanyl Meds
Since 2007, the FDA has been discussing and debating the development of Risk Evaluation and Mitigation Strategies (REMS) for opioid... Read more »
Fentanyl Patch Recall Expanded
Two weeks ago we told you that the 25mcg/hr fentanyl transdermal system patches (also known as Duragesic patches) were being recalled due... Read more »
More Than One Million Fentanyl Patches Recalled
Late yesterday Actavis Inc. announced a voluntary recall of 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches manufactured... Read more »
Fentanyl Patch Recall Announced
Watson Pharmaceuticals, Inc. announced Tuesday that one lot of 100 mcg/hr Fentanyl Transdermal System patches sold in the U.S. is being... Read more »
From Our Sources
Clinical trial: Fentanyl buccal tablets vs. oxycodone for chro...
This is a study to compare the effects of fentanyl buccal tablets with those of immediate-release oxycodone in relieving breakthrough pain in people... Read more »
Some fentanyl patches recalled
Drugmaker Watson Pharmaceuticals has voluntarily recalled one production batch of its Fentanyl Transdermal System patches. The drugmaker reports... Read more »
Nearly 1 Million Fentanyl Pain Patches Recalled
The U.S. Food and Drug Administration (FDA) and drugmaker Actavis Inc. have announced that about one million fentanyl patches used to treat such... Read more »
Clinical trial: OraVescent fentanyl for treating chronic pain
This is a study to evaluate the safety and effectiveness of OraVescent fentanyl compared to placebo in relieving breakthrough pain in patients with... Read more »
FDA approves new generic fentanyl patch
The Food and Drug Administration has approved a new generic fentanyl patch for the management of chronic pain. The patch is designed to be used twice... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
